VS
Verastem, Inc.
VSTM · NASDAQ
$7.32 -5.55% (-$0.43)
1M +9.75%
Market Cap $669.6M
P/E Ratio -
Div. Yield -
ROE 467.49%
Bulios Fair Price
$4.08
44.3% downside
Current Price
$7.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VSTM is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
4 /100
Expensive P/S 7.65x
P/B 13.40x
P/E N/A
Growth
91 /100
Growing Rev. growth 128.36%
Book val. growth 6.47%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.69%
Net margin 231.59%
FCF margin 186.85%
Quality
5 /100
Poor ROIC 119.01%
ROE 467.49%
Asset turnover 0.42x
Debt
36 /100
Moderate Debt/Equity 1.69x
Current ratio 2.25x
Int. coverage -135.99x
Stability
55 /100
Moderate Beta 0.32x
EPS volatility 4.98%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VSTM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel W. Paterson
Employees
102
Headquarters
Needham
Upcoming events
03 NOV
Earnings
Upcoming earnings report